Evidence map›Paper›PMID 41415588›Full record

ReviewBrain & NeuroRehabilitation2025

Clinical Framework for Motor Rehabilitation in Parkinsonism: Integrating Individualized and Syndrome-Specific Approaches.

Doo Young Kim

Abstract readReview
In one paragraph

Review in Brain & NeuroRehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Doo Young KimDepartment of Rehabilitation Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.ORCID https://orcid.org/0000-0003-1327-5348

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review presents a clinical framework for motor rehabilitation in patients with Parkinson's disease and atypical parkinsonian syndromes. Its purpose is to provide practical, individualized rehabilitation strategies that consider both disease stage and the clinical characteristics of each syndrome. Motor symptoms such as bradykinesia, rigidity, postural instability, and gait disturbance are major contributors to disability and reduced independence in these populations. Although pharmacological treatment remains fundamental, rehabilitation is crucial for maintaining mobility and preventing falls. This review discusses stage-based approaches, including early education in self-management and compensatory movement strategies, as well as advanced interventions for patients with severe motor dysfunction. Syndrome-specific features are also addressed. For example, patients with progressive supranuclear palsy often exhibit early axial rigidity and postural extension, while those with multiple system atrophy may experience cerebellar ataxia or autonomic dysfunction. In corticobasal degeneration, motor planning deficits and sensory loss may resemble symptoms seen in cortical stroke. Additionally, the review emphasizes the importance of recognizing and managing dystonia, which can further impair motor function and safety. While the primary focus is on motor symptoms, the influence of non-motor features such as cognitive impairment and autonomic instability is also acknowledged in rehabilitation planning. Overall, this review aims to support clinical decision-making through a structured, patient-centered approach to motor rehabilitation in parkinsonism.

Indexed as

DystoniaMotor ActivityParkinson DiseaseParkinsonian DisordersRehabilitation

Identifiers

PMID41415588
PMCPMC12710285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.